Who Owns DexCom Stock?
NASDAQ: DXCMHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 84.11 0.00%
Ownership breakdown
- Held by institutions
- 106.71%
- Institutions (% of float)
- 106.99%
- Held by insiders
- 0.26%
- Institutional holders
- 1,466
- Institutions 99.7%
- Insiders 0.3%
- Public and other 0.0%
Who owns DexCom stock?
Institutional investors own about 106.7% of DexCom's shares, spread across 1,466 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.26% of DXCM.
The largest institutional holders are Blackrock Inc. (10.13%), Vanguard Capital Management LLC (6.68%) and Vanguard Portfolio Management LLC (5.21%). Together, the top 10 institutions control 46.5% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their DXCM positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of DXCM
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 38.24M | 10.13% | -1.9% |
| Vanguard Capital Management LLC | 25.21M | 6.68% | +0.8% |
| Vanguard Portfolio Management LLC | 19.66M | 5.21% | +2.3% |
| State Street Corporation | 18.38M | 4.87% | +2.5% |
| Invesco Ltd. | 15.29M | 4.05% | +11.8% |
| BAILLIE GIFFORD & CO | 14.80M | 3.92% | -5.1% |
| Geode Capital Management, LLC | 12.43M | 3.29% | +0.7% |
| Alliancebernstein L.P. | 11.69M | 3.10% | -9.5% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 11.26M | 2.98% | +15.6% |
| Wellington Management Group, LLP | 8.53M | 2.26% | -8.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of DXCM
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 12.25M | 3.25% |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 10.00M | 2.65% |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 8.36M | 2.22% |
| Invesco QQQ Trust, Series 1 | 8.30M | 2.20% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 5.38M | 1.43% |
| iShares Trust-iShares Core S&P 500 ETF | 5.14M | 1.36% |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 5.01M | 1.33% |
| VANGUARD INDEX FUNDS-Vanguard Growth Index Fund | 4.95M | 1.31% |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 4.71M | 1.25% |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Growth Index Fund | 2.96M | 0.78% |
Frequently asked questions
Who is the largest shareholder of DexCom?
Blackrock Inc. is the largest institutional shareholder of DXCM, owning 10.13% of shares outstanding (38.24M shares) as of its latest 13F filing.
What percentage of DexCom is owned by institutions?
Institutions own about 106.7% of DXCM shares and 107.0% of the public float.
How much of DexCom do insiders own?
Insiders, such as officers and directors, own about 0.26% of DXCM shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.